Enabling an Accelerated Development Path for Chlorhexidine Digluconate Gel 7.1% w/w for the Prevention of Omphalitis
In 2012, the United Nations (UN), identified chlorhexidine as a Life-saving Commodity and called for the development of a chlorhexidine product suitable for the prevention of omphalitis (umbilical cord infection) in developing countries. In response, GlaxoSmithKline (GSK) set out to develop a chlorh...
Saved in:
Main Authors: | Elena De Angelis (Author), L Immins (Author), N Jibry (Author), D Hunt (Author), K Cheng (Author), P Chowdhury (Author), C Patel (Author), S Wilhelm (Author), P Williams (Author) |
---|---|
Format: | Book |
Published: |
University of Huddersfield Press,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chlorhexidine and newborn omphalitis and mortality
by: Stephen Hodgins
Published: (2017) -
Chlorhexidine and newborn omphalitis and mortality - Authors' reply
by: David Osrin, et al.
Published: (2017) -
Antimicrobial efficacy of the combination of chlorhexidine digluconate and dexpanthenol
by: Kramer, Axel, et al.
Published: (2016) -
Adoption and factors associated with 7.1% chlorhexidine digluconate cord care standards in public health facilities in Kiambu County, Kenya
by: James Maina Githinji, et al.
Published: (2024) -
Cost and consequences of using 7.1 % chlorhexidine gel for newborn umbilical cord care in Kenya
by: Lecia Brown, et al.
Published: (2021)